Edition:
India

NMC Health PLC (NMC.L)

NMC.L on London Stock Exchange

2,438.00GBp
9:09pm IST
Change (% chg)

-35.00 (-1.42%)
Prev Close
2,473.00
Open
2,551.00
Day's High
2,596.00
Day's Low
2,415.00
Volume
649,288
Avg. Vol
697,605
52-wk High
4,376.00
52-wk Low
2,110.00

Latest Key Developments (Source: Significant Developments)

NMC Health Says FY Adjusted Profit $283.5 Mln
Thursday, 7 Mar 2019 

March 7 (Reuters) - NMC Health PLC ::FY REVENUE $2,057.3 MILLION VERSUS $1,603.4 MILLION.FY ADJUSTED PROFIT $283.5 MILLION VERSUS $236.6 MILLION.ORGANIC REVENUE GROWTH FOR FY 2018 AHEAD OF GUIDANCE AT 15.4% YOY.REMAIN CONFIDENT THAT 2019 WILL PROVE TO BE ANOTHER YEAR OF RECORD TOP AND BOTTOM LINE.NMC ALSO CONTINUES TO BENEFIT FROM SUSTAINED ECONOMIC EXPANSION IN ITS CORE MARKETS.  Full Article

NMC Health To Form Healthcare JV With Hassana Investment Co
Tuesday, 5 Mar 2019 

March 5 (Reuters) - NMC Health PLC ::UPDATE ON KSA JOINT VENTURE.SIGNING OF DEFINITIVE DOCUMENTS TO FORM A JOINT VENTURE IN HEALTHCARE WITH HASSANA INVESTMENT COMPANY.ALL COMMERCIAL TERMS AND AGREEMENTS HAVE BEEN FINALISED BETWEEN NMC AND HASSANA.JV IS FORMED BY NMC'S CONTRIBUTION OF ITS FIVE ASSETS IN KSA AND AN ADDITIONAL CASH INJECTION AT CLOSING.JV ALSO INCLUDES GOSI'S CONTRIBUTION OF 38.88% STAKE IN TADAWUL-LISTED NATIONAL MEDICAL CARE COMPANY AT A PRICE OF SAR 54 PER SHARE.AT CLOSING OF TRANSACTION, NMC WILL OWN A 52% STAKE (THROUGH COMBINATION OF ASSET CONTRIBUTION AND CASH INJECTION).NMC WILL HAVE OPERATIONAL CONTROL OF JV.  Full Article

NMC Health Says Comfortable With 2018, 2019 Guidance
Monday, 10 Dec 2018 

Dec 10 (Reuters) - NMC Health PLC ::TRADING UPDATE.FY REVENUE 1.6 BILLION USD.MANAGEMENT REMAINS COMFORTABLE WITH FINANCIAL GUIDANCE IT PROVIDED FOR 2018 AND 2019.KSA JOINT-VENTURE PROGRESSING WELL, FINAL AGREEMENT EXPECTED TO BE SIGNED IN EARLY Q1 2019.OPTED TO REVISE KPIS FOR MANAGEMENT LTIP TO "BETTER ALIGN WITH SHAREHOLDER VALUE CREATION".NMC HEALTH - TO INCREASE EBITDA GROWTH PERFORMANCE REQUIREMENT FOR 2019 LTIP AWARDS FROM 5-15% TO 10-18% (CAGR) AT THRESHOLD AND MAXIMUM RESPECTIVELY.TO INTRODUCE AN ADDITIONAL UNDERPIN CAPTURING CONVERSION OF EBITDA TO NET INCOME.  Full Article

NMC Health H1 Revenue Rose 20.2 Pct To 932 Mln Dollars
Monday, 20 Aug 2018 

Aug 20 (Reuters) - NMC Health PLC ::H1 REVENUE ROSE 20.2 PERCENT TO 932 MILLION USD.HY EBITDA $225.5 MILLION VERSUS. $170.7 MILLION.FINANCIAL AND OPERATIONAL PERFORMANCE DURING H1 2018 REMAINED IN LINE WITH EXPECTATIONS.MANAGEMENT MAINTAINING POSITIVE OUTLOOK FOR H2 2018.  Full Article

Saudi's Al Hammadi Decides to Discontinue Merger Talks With Care
Sunday, 24 Jun 2018 

June 24 (Reuters) - AL HAMMADI COMPANY FOR DEVELOPMENT AND INVESTMENT <4007.SE>::ANNOUNCES DISCONTINUING THE PRELIMINARY DISCUSSIONS WITH NATIONAL MEDICAL CARE COMPANY (CARE) IN RELATION TO THE CONSIDERATION OF THE POTENTIAL MERGER OF THE COMPANIES.  Full Article

NMC Health Says Placement Of $450 Mln Bonds By NMC HEALTH (JERSEY)
Monday, 23 Apr 2018 

April 23 (Reuters) - NMC Health PLC ::PLACEMENT OF USD 450 MILLION BONDS.SAYS UNIT NMC HEALTH (JERSEY) PLACES USD 450 MILLION SENIOR UNSECURED GUARANTEED BONDS DUE 2025 CONVERTIBLE INTO ORDINARY SHARES OF NMC HEALTH.CONVERTIBLE BONDS WILL CARRY A COUPON OF 1.875% AND AN INITIAL EXCHANGE PRICE OF USD 72.7301.NET PROCEEDS OF OFFERING WILL BE USED IN TOTALITY TO REPAY PART OF CURRENT USD 1 BILLION BRIDGE FACILITY.J.P. MORGAN CAZENOVE ACTED AS SOLE BOOKRUNNER AND HSBC ACTED AS LEAD MANAGER.  Full Article

NMC Health Says Spouse Of Independent Non-Exec Joint Chair Sold 1,000 Ordinary Shares
Thursday, 29 Mar 2018 

March 29 (Reuters) - NMC Health Plc ::SPOUSE OF MARK TOMPKINS, NMC'S INDEPENDENT NON-EXEC JOINT CHAIR, ON 28 MARCH SOLD 1,000 ORDINARY SHARES OF 10P EACH IN CO AT 3430.808P.  Full Article

NMC Health Says Acquisition Of 70% Stake In Cosmesurge And Related Businesses​
Monday, 22 Jan 2018 

Jan 22 (Reuters) - NMC Health Plc ::‍ANNOUNCE TWO ACQUISITIONS AND COMPLETION OF NEW OPERATING AND MANAGEMENT (O&M) CONTRACTS​.‍SAYS ACQUISITION OF 70% STAKE IN COSMESURGE AND RELATED BUSINESSES​.‍PURCHASE CONSIDERATION FOR COSMESURGE DEAL OF USD 170MN, TRANSLATING INTO 10.6X 2018E EV/EBITDA​.SAYS ACQUISITION OF 80% STAKE IN RIYADH-BASED AL SALAM MEDICAL GROUP​.NMC HEALTH - ‍INITIAL CONSIDERATION OF C. $37MN PAYABLE UPON CLOSING AND DEFERRED CONSIDERATION TO BE PAID AFTER 1 YEAR BASED ON BUSINESS'S FINANCIAL PERFORMANCE FOR AL SALAM DEAL ​.  Full Article